Share Price and Basic Stock Data
Last Updated: January 29, 2026, 7:07 pm
| PEG Ratio | -2.75 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
UPL Ltd, a prominent player in the agrochemicals and pesticides industry, reported a current market price of ₹715 with a market capitalization of ₹60,313 Cr. The company’s sales figures have shown a fluctuating trend in recent quarters, with reported sales of ₹12,507 Cr in September 2022, peaking at ₹16,569 Cr in March 2023 before declining to ₹8,963 Cr in June 2023. Subsequent quarters reflected a recovery, with sales of ₹10,170 Cr in September 2023 and projected sales of ₹14,078 Cr by March 2024. Over the fiscal year ending March 2023, UPL recorded total sales of ₹53,576 Cr, which was a significant increase compared to ₹46,240 Cr in the previous year. This growth trajectory reflects the company’s strategic positioning within the agrochemical sector, despite facing challenges such as fluctuating commodity prices and changing regulatory landscapes. The trailing twelve-month (TTM) sales stood at ₹47,715 Cr, indicating a stable revenue generation capability.
Profitability and Efficiency Metrics
UPL’s profitability metrics have exhibited volatility, with a reported net profit of ₹2,368 Cr for the trailing twelve months, translating to a P/E ratio of 25.4. The company faced a net profit decline in recent quarters, recording a loss of ₹1,607 Cr in December 2023, which marked a significant dip from the net profit of ₹1,080 Cr in March 2023. Operating Profit Margin (OPM) fluctuated considerably, standing at 16% for the TTM, but dropping to as low as 1% in December 2023. The return on equity (ROE) stood at 3.29%, while return on capital employed (ROCE) was reported at 7.66%. These figures indicate that while UPL has managed to generate profit, its efficiency in utilizing equity and capital remains below optimal levels compared to sector averages. The company’s Cash Conversion Cycle (CCC) of 112 days suggests a relatively longer duration for converting investments into cash, which may impact liquidity.
Balance Sheet Strength and Financial Ratios
UPL’s balance sheet reflects a robust asset base with total assets recorded at ₹91,391 Cr as of September 2025. The company reported borrowings amounting to ₹30,022 Cr, resulting in a total debt to equity ratio of 0.81, indicating a moderate leverage position. Reserves increased to ₹31,725 Cr, demonstrating a commitment to reinvestment and financial prudence. The interest coverage ratio (ICR) stood at 2.23x, suggesting that the company can comfortably meet its interest obligations, although this is a decline from previous years. The price to book value (P/BV) ratio of 1.73x reflects a valuation that is slightly above typical sector levels, indicating investor confidence in the company’s growth potential. However, the declining trend in ROCE to 8.97% in March 2025 from 14% in March 2023 raises concerns about the efficiency of capital deployment. The balance sheet’s stability is crucial for navigating future growth opportunities and potential market fluctuations.
Shareholding Pattern and Investor Confidence
As of September 2025, UPL’s shareholding pattern indicates a diversified ownership structure, with promoters holding 33.49%, foreign institutional investors (FIIs) at 37.01%, domestic institutional investors (DIIs) at 17.17%, and the public holding 12.33%. This distribution reflects a healthy level of institutional interest, particularly from FIIs, which signifies confidence in UPL’s long-term prospects. The number of shareholders has seen significant growth, increasing from 2,53,054 in December 2022 to 2,84,675 by September 2025, indicating rising retail investor interest. However, the decline in FIIs from 38.69% in March 2023 to 34.90% in June 2025 may raise some concerns regarding foreign investor sentiment. The stability of the promoter stake, which has remained relatively constant, underscores their confidence in the company’s strategic direction and long-term viability, providing a foundation for potential recovery in investor sentiment.
Outlook, Risks, and Final Insight
UPL’s outlook remains cautiously optimistic, supported by its strong market presence and comprehensive product portfolio in the agrochemical sector. However, the company faces significant risks, including fluctuating raw material costs, regulatory changes, and increasing competition, which could impact profitability. The volatility in quarterly net profit, particularly the losses reported in late 2023, raises questions about operational efficiency and market dynamics. Strengths include a solid balance sheet with growing reserves and a diversified shareholder base that provides stability. The company’s ability to navigate these challenges while capitalizing on growth opportunities in emerging markets will be crucial for sustaining its competitive edge. In scenarios of improved operational efficiency and favorable market conditions, UPL could potentially enhance its profitability and investor confidence, paving the way for a stronger financial performance moving forward.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 4,443 Cr. | 1,030 | 2,114/1,026 | 11.0 | 487 | 0.58 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 772 Cr. | 228 | 391/165 | 15.9 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 55.7 Cr. | 107 | 149/56.6 | 9.98 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,614 Cr. | 202 | 331/198 | 98.6 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 706 Cr. | 19.9 | 35.8/16.3 | 55.1 | 22.8 | 1.01 % | 12.9 % | 9.95 % | 1.00 |
| Industry Average | 10,458.85 Cr | 1,073.03 | 28.83 | 369.04 | 0.45% | 15.21% | 19.87% | 6.67 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12,507 | 13,679 | 16,569 | 8,963 | 10,170 | 9,887 | 14,078 | 9,067 | 11,090 | 10,907 | 15,573 | 9,216 | 12,019 |
| Expenses | 10,090 | 10,795 | 13,847 | 7,747 | 9,049 | 9,820 | 12,230 | 7,998 | 9,873 | 9,229 | 12,409 | 7,820 | 10,072 |
| Operating Profit | 2,417 | 2,884 | 2,722 | 1,216 | 1,121 | 67 | 1,848 | 1,069 | 1,217 | 1,678 | 3,164 | 1,396 | 1,947 |
| OPM % | 19% | 21% | 16% | 14% | 11% | 1% | 13% | 12% | 11% | 15% | 20% | 15% | 16% |
| Other Income | 35 | 129 | 302 | 58 | 18 | 134 | 66 | 49 | 103 | 94 | -168 | 152 | 392 |
| Interest | 644 | 894 | 906 | 700 | 871 | 1,191 | 1,090 | 913 | 1,070 | 730 | 914 | 1,007 | 784 |
| Depreciation | 608 | 624 | 727 | 636 | 657 | 676 | 794 | 660 | 697 | 688 | 705 | 731 | 771 |
| Profit before tax | 1,200 | 1,495 | 1,391 | -62 | -389 | -1,666 | 30 | -455 | -447 | 354 | 1,377 | -190 | 784 |
| Tax % | 19% | 9% | 22% | -265% | -25% | -4% | 367% | 16% | 31% | -141% | 22% | -7% | 22% |
| Net Profit | 969 | 1,360 | 1,080 | 102 | -293 | -1,607 | -80 | -527 | -585 | 853 | 1,079 | -176 | 612 |
| EPS in Rs | 9.64 | 12.87 | 9.38 | 1.97 | -2.24 | -14.41 | 0.47 | -4.55 | -5.25 | 9.81 | 10.61 | -1.04 | 6.56 |
Last Updated: December 28, 2025, 4:33 pm
Below is a detailed analysis of the quarterly data for UPL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 12,019.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,216.00 Cr. (Jun 2025) to 12,019.00 Cr., marking an increase of 2,803.00 Cr..
- For Expenses, as of Sep 2025, the value is 10,072.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,820.00 Cr. (Jun 2025) to 10,072.00 Cr., marking an increase of 2,252.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 1,947.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,396.00 Cr. (Jun 2025) to 1,947.00 Cr., marking an increase of 551.00 Cr..
- For OPM %, as of Sep 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Jun 2025) to 16.00%, marking an increase of 1.00%.
- For Other Income, as of Sep 2025, the value is 392.00 Cr.. The value appears strong and on an upward trend. It has increased from 152.00 Cr. (Jun 2025) to 392.00 Cr., marking an increase of 240.00 Cr..
- For Interest, as of Sep 2025, the value is 784.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,007.00 Cr. (Jun 2025) to 784.00 Cr., marking a decrease of 223.00 Cr..
- For Depreciation, as of Sep 2025, the value is 771.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 731.00 Cr. (Jun 2025) to 771.00 Cr., marking an increase of 40.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 784.00 Cr.. The value appears strong and on an upward trend. It has increased from -190.00 Cr. (Jun 2025) to 784.00 Cr., marking an increase of 974.00 Cr..
- For Tax %, as of Sep 2025, the value is 22.00%. The value appears to be increasing, which may not be favorable. It has increased from -7.00% (Jun 2025) to 22.00%, marking an increase of 29.00%.
- For Net Profit, as of Sep 2025, the value is 612.00 Cr.. The value appears strong and on an upward trend. It has increased from -176.00 Cr. (Jun 2025) to 612.00 Cr., marking an increase of 788.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 6.56. The value appears strong and on an upward trend. It has increased from -1.04 (Jun 2025) to 6.56, marking an increase of 7.60.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,771 | 12,091 | 14,048 | 16,312 | 17,378 | 21,837 | 35,756 | 38,694 | 46,240 | 53,576 | 43,098 | 46,637 | 47,715 |
| Expenses | 8,753 | 9,728 | 11,700 | 13,346 | 13,966 | 18,024 | 28,984 | 30,342 | 36,711 | 43,380 | 38,801 | 39,509 | 39,530 |
| Operating Profit | 2,018 | 2,363 | 2,348 | 2,966 | 3,412 | 3,813 | 6,772 | 8,352 | 9,529 | 10,196 | 4,297 | 7,128 | 8,185 |
| OPM % | 19% | 20% | 17% | 18% | 20% | 17% | 19% | 22% | 21% | 19% | 10% | 15% | 17% |
| Other Income | 30 | -11 | 149 | 363 | 351 | -197 | -515 | 62 | 91 | 464 | 231 | 78 | 470 |
| Interest | 485 | 517 | 704 | 735 | 783 | 963 | 1,481 | 2,060 | 2,295 | 2,963 | 3,852 | 3,627 | 3,435 |
| Depreciation | 407 | 425 | 676 | 672 | 675 | 880 | 2,012 | 2,173 | 2,359 | 2,547 | 2,763 | 2,750 | 2,895 |
| Profit before tax | 1,157 | 1,410 | 1,117 | 1,922 | 2,305 | 1,773 | 2,764 | 4,181 | 4,966 | 5,150 | -2,087 | 829 | 2,325 |
| Tax % | 19% | 17% | 15% | 10% | 12% | 11% | 21% | 16% | 11% | 14% | -10% | 1% | |
| Net Profit | 957 | 1,187 | 952 | 1,733 | 2,030 | 1,575 | 2,178 | 3,495 | 4,437 | 4,414 | -1,878 | 820 | 2,368 |
| EPS in Rs | 13.13 | 15.82 | 13.00 | 20.18 | 23.57 | 17.35 | 20.66 | 33.40 | 42.18 | 42.28 | -14.21 | 10.62 | 25.94 |
| Dividend Payout % | 18% | 19% | 23% | 20% | 20% | 27% | 26% | 27% | 21% | 21% | -6% | 53% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 24.03% | -19.80% | 82.04% | 17.14% | -22.41% | 38.29% | 60.47% | 26.95% | -0.52% | -142.55% | 143.66% |
| Change in YoY Net Profit Growth (%) | 0.00% | -43.83% | 101.84% | -64.90% | -39.55% | 60.70% | 22.18% | -33.52% | -27.47% | -142.03% | 286.21% |
UPL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 5% |
| 3 Years: | 0% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -16% |
| 3 Years: | -38% |
| TTM: | 182% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | -1% |
| 1 Year: | 17% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 8% |
| 3 Years: | 4% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:10 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 86 | 86 | 86 | 101 | 102 | 102 | 153 | 153 | 153 | 150 | 150 | 159 | 169 |
| Reserves | 5,162 | 5,775 | 5,803 | 7,214 | 9,067 | 14,613 | 19,129 | 20,734 | 24,508 | 26,708 | 24,657 | 29,054 | 31,725 |
| Borrowings | 3,349 | 3,281 | 5,258 | 6,443 | 6,638 | 29,139 | 29,388 | 24,519 | 26,746 | 23,939 | 29,754 | 25,099 | 30,022 |
| Other Liabilities | 4,162 | 5,143 | 5,722 | 6,454 | 7,148 | 18,581 | 19,758 | 23,359 | 29,196 | 35,318 | 30,579 | 31,700 | 29,475 |
| Total Liabilities | 12,759 | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 86,012 | 91,391 |
| Fixed Assets | 3,821 | 4,031 | 3,862 | 4,071 | 4,437 | 32,149 | 35,321 | 34,765 | 36,193 | 38,713 | 39,056 | 39,084 | 42,247 |
| CWIP | 228 | 583 | 484 | 792 | 1,319 | 1,855 | 2,073 | 2,117 | 2,501 | 2,818 | 2,965 | 2,546 | 794 |
| Investments | 737 | 764 | 335 | 378 | 1,034 | 708 | 558 | 618 | 1,922 | 1,615 | 2,154 | 2,328 | 2,604 |
| Other Assets | 7,973 | 8,906 | 12,188 | 14,971 | 16,165 | 27,723 | 30,476 | 31,265 | 39,987 | 42,969 | 40,965 | 42,054 | 45,746 |
| Total Assets | 12,759 | 14,284 | 16,869 | 20,212 | 22,955 | 62,435 | 68,428 | 68,765 | 80,603 | 86,115 | 85,140 | 86,012 | 91,391 |
Below is a detailed analysis of the balance sheet data for UPL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 169.00 Cr.. The value appears strong and on an upward trend. It has increased from 159.00 Cr. (Mar 2025) to 169.00 Cr., marking an increase of 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 31,725.00 Cr.. The value appears strong and on an upward trend. It has increased from 29,054.00 Cr. (Mar 2025) to 31,725.00 Cr., marking an increase of 2,671.00 Cr..
- For Borrowings, as of Sep 2025, the value is 30,022.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 25,099.00 Cr. (Mar 2025) to 30,022.00 Cr., marking an increase of 4,923.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 29,475.00 Cr.. The value appears to be improving (decreasing). It has decreased from 31,700.00 Cr. (Mar 2025) to 29,475.00 Cr., marking a decrease of 2,225.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 91,391.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 86,012.00 Cr. (Mar 2025) to 91,391.00 Cr., marking an increase of 5,379.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 42,247.00 Cr.. The value appears strong and on an upward trend. It has increased from 39,084.00 Cr. (Mar 2025) to 42,247.00 Cr., marking an increase of 3,163.00 Cr..
- For CWIP, as of Sep 2025, the value is 794.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,546.00 Cr. (Mar 2025) to 794.00 Cr., marking a decrease of 1,752.00 Cr..
- For Investments, as of Sep 2025, the value is 2,604.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,328.00 Cr. (Mar 2025) to 2,604.00 Cr., marking an increase of 276.00 Cr..
- For Other Assets, as of Sep 2025, the value is 45,746.00 Cr.. The value appears strong and on an upward trend. It has increased from 42,054.00 Cr. (Mar 2025) to 45,746.00 Cr., marking an increase of 3,692.00 Cr..
- For Total Assets, as of Sep 2025, the value is 91,391.00 Cr.. The value appears strong and on an upward trend. It has increased from 86,012.00 Cr. (Mar 2025) to 91,391.00 Cr., marking an increase of 5,379.00 Cr..
Notably, the Reserves (31,725.00 Cr.) exceed the Borrowings (30,022.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.00 | -1.00 | -3.00 | -4.00 | -3.00 | -26.00 | -23.00 | -16.00 | -17.00 | -13.00 | -25.00 | -18.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 109 | 115 | 133 | 127 | 127 | 195 | 121 | 115 | 121 | 124 | 138 | 121 |
| Inventory Days | 166 | 178 | 204 | 194 | 204 | 306 | 153 | 180 | 216 | 187 | 198 | 167 |
| Days Payable | 181 | 195 | 213 | 228 | 255 | 330 | 199 | 244 | 274 | 236 | 196 | 176 |
| Cash Conversion Cycle | 95 | 98 | 124 | 93 | 76 | 171 | 75 | 51 | 64 | 76 | 141 | 112 |
| Working Capital Days | 64 | 45 | 48 | 84 | 94 | 127 | 59 | 52 | 38 | 46 | 52 | 9 |
| ROCE % | 19% | 21% | 19% | 22% | 21% | 10% | 10% | 13% | 14% | 14% | 3% | 8% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Multi Asset Fund | 4,689,655 | 0.48 | 372.9 | 5,607,611 | 2026-01-26 03:43:03 | -16.37% |
| ICICI Prudential MidCap Fund | 3,465,469 | 3.86 | 275.56 | N/A | N/A | N/A |
| ICICI Prudential Multicap Fund | 2,807,724 | 1.37 | 223.26 | N/A | N/A | N/A |
| Mirae Asset Midcap Fund | 2,798,281 | 1.21 | 222.51 | 2,477,280 | 2025-12-15 01:14:10 | 12.96% |
| ICICI Prudential India Opportunities Fund | 2,741,547 | 0.63 | 217.99 | 3,155,047 | 2025-12-15 01:14:10 | -13.11% |
| ICICI Prudential Commodities Fund | 2,533,721 | 5.91 | 201.47 | 2,093,346 | 2025-12-15 01:14:10 | 21.04% |
| Tata Mid Cap Fund | 2,300,000 | 3.33 | 182.88 | 2,100,000 | 2026-01-26 03:43:04 | 9.52% |
| ICICI Prudential Large & Mid Cap Fund | 1,866,675 | 0.53 | 148.43 | 4,346,820 | 2026-01-26 03:43:03 | -57.06% |
| Old Bridge Focused Fund | 1,480,300 | 4.91 | 117.71 | N/A | N/A | N/A |
| Franklin India Opportunities Fund | 1,445,260 | 1.37 | 114.92 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 9.85 | -17.80 | 45.79 | 45.87 | 36.40 |
| Diluted EPS (Rs.) | 9.62 | -17.80 | 45.79 | 45.87 | 36.40 |
| Cash EPS (Rs.) | 50.84 | 15.03 | 90.72 | 87.08 | 73.54 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 367.46 | 330.76 | 432.57 | 344.08 | 282.27 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 367.46 | 330.76 | 432.57 | 344.08 | 282.27 |
| Revenue From Operations / Share (Rs.) | 586.63 | 574.64 | 714.35 | 604.44 | 505.80 |
| PBDIT / Share (Rs.) | 101.71 | 66.96 | 142.31 | 128.24 | 112.55 |
| PBIT / Share (Rs.) | 67.12 | 30.12 | 108.35 | 97.40 | 84.14 |
| PBT / Share (Rs.) | 16.36 | -24.60 | 66.57 | 63.16 | 54.10 |
| Net Profit / Share (Rs.) | 16.25 | -21.81 | 56.76 | 56.25 | 45.14 |
| NP After MI And SOA / Share (Rs.) | 11.28 | -16.00 | 47.60 | 47.40 | 37.53 |
| PBDIT Margin (%) | 17.33 | 11.65 | 19.92 | 21.21 | 22.25 |
| PBIT Margin (%) | 11.44 | 5.24 | 15.16 | 16.11 | 16.63 |
| PBT Margin (%) | 2.78 | -4.28 | 9.31 | 10.44 | 10.69 |
| Net Profit Margin (%) | 2.77 | -3.79 | 7.94 | 9.30 | 8.92 |
| NP After MI And SOA Margin (%) | 1.92 | -2.78 | 6.66 | 7.84 | 7.41 |
| Return on Networth / Equity (%) | 3.07 | -4.83 | 13.29 | 16.72 | 16.03 |
| Return on Capital Employeed (%) | 8.97 | 3.72 | 13.64 | 13.67 | 12.67 |
| Return On Assets (%) | 1.01 | -1.37 | 4.03 | 4.38 | 4.07 |
| Long Term Debt / Equity (X) | 0.62 | 0.96 | 0.75 | 0.99 | 1.24 |
| Total Debt / Equity (X) | 0.81 | 1.15 | 0.85 | 1.19 | 1.32 |
| Asset Turnover Ratio (%) | 0.53 | 0.48 | 0.37 | 0.36 | 0.26 |
| Current Ratio (X) | 1.39 | 1.46 | 1.45 | 1.41 | 1.53 |
| Quick Ratio (X) | 1.03 | 0.98 | 0.96 | 0.94 | 1.05 |
| Inventory Turnover Ratio (X) | 4.04 | 3.22 | 1.45 | 1.41 | 1.15 |
| Dividend Payout Ratio (NP) (%) | 8.36 | -62.41 | 21.03 | 21.07 | 15.95 |
| Dividend Payout Ratio (CP) (%) | 2.05 | 47.92 | 12.27 | 12.76 | 9.08 |
| Earning Retention Ratio (%) | 91.64 | 162.41 | 78.97 | 78.93 | 84.05 |
| Cash Earning Retention Ratio (%) | 97.95 | 52.08 | 87.73 | 87.24 | 90.92 |
| Interest Coverage Ratio (X) | 2.23 | 1.30 | 3.60 | 4.27 | 4.18 |
| Interest Coverage Ratio (Post Tax) (X) | 1.47 | 0.64 | 2.49 | 3.02 | 2.79 |
| Enterprise Value (Cr.) | 70381.90 | 61503.75 | 76295.75 | 83275.05 | 71528.30 |
| EV / Net Operating Revenue (X) | 1.51 | 1.43 | 1.42 | 1.80 | 1.85 |
| EV / EBITDA (X) | 8.70 | 12.25 | 7.15 | 8.49 | 8.31 |
| MarketCap / Net Operating Revenue (X) | 1.08 | 0.79 | 1.00 | 1.27 | 1.27 |
| Retention Ratios (%) | 91.63 | 162.41 | 78.96 | 78.92 | 84.04 |
| Price / BV (X) | 1.73 | 1.38 | 2.00 | 2.72 | 2.74 |
| Price / Net Operating Revenue (X) | 1.08 | 0.79 | 1.00 | 1.27 | 1.27 |
| EarningsYield | 0.01 | -0.03 | 0.06 | 0.06 | 0.05 |
After reviewing the key financial ratios for UPL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 9.85. This value is within the healthy range. It has increased from -17.80 (Mar 24) to 9.85, marking an increase of 27.65.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.62. This value is within the healthy range. It has increased from -17.80 (Mar 24) to 9.62, marking an increase of 27.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 50.84. This value is within the healthy range. It has increased from 15.03 (Mar 24) to 50.84, marking an increase of 35.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 367.46. It has increased from 330.76 (Mar 24) to 367.46, marking an increase of 36.70.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 367.46. It has increased from 330.76 (Mar 24) to 367.46, marking an increase of 36.70.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 586.63. It has increased from 574.64 (Mar 24) to 586.63, marking an increase of 11.99.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 101.71. This value is within the healthy range. It has increased from 66.96 (Mar 24) to 101.71, marking an increase of 34.75.
- For PBIT / Share (Rs.), as of Mar 25, the value is 67.12. This value is within the healthy range. It has increased from 30.12 (Mar 24) to 67.12, marking an increase of 37.00.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.36. This value is within the healthy range. It has increased from -24.60 (Mar 24) to 16.36, marking an increase of 40.96.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 16.25. This value is within the healthy range. It has increased from -21.81 (Mar 24) to 16.25, marking an increase of 38.06.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.28. This value is within the healthy range. It has increased from -16.00 (Mar 24) to 11.28, marking an increase of 27.28.
- For PBDIT Margin (%), as of Mar 25, the value is 17.33. This value is within the healthy range. It has increased from 11.65 (Mar 24) to 17.33, marking an increase of 5.68.
- For PBIT Margin (%), as of Mar 25, the value is 11.44. This value is within the healthy range. It has increased from 5.24 (Mar 24) to 11.44, marking an increase of 6.20.
- For PBT Margin (%), as of Mar 25, the value is 2.78. This value is below the healthy minimum of 10. It has increased from -4.28 (Mar 24) to 2.78, marking an increase of 7.06.
- For Net Profit Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 5. It has increased from -3.79 (Mar 24) to 2.77, marking an increase of 6.56.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.92. This value is below the healthy minimum of 8. It has increased from -2.78 (Mar 24) to 1.92, marking an increase of 4.70.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.07. This value is below the healthy minimum of 15. It has increased from -4.83 (Mar 24) to 3.07, marking an increase of 7.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. It has increased from 3.72 (Mar 24) to 8.97, marking an increase of 5.25.
- For Return On Assets (%), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 5. It has increased from -1.37 (Mar 24) to 1.01, marking an increase of 2.38.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.62. This value is within the healthy range. It has decreased from 0.96 (Mar 24) to 0.62, marking a decrease of 0.34.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.81. This value is within the healthy range. It has decreased from 1.15 (Mar 24) to 0.81, marking a decrease of 0.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.53. It has increased from 0.48 (Mar 24) to 0.53, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.39, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has increased from 0.98 (Mar 24) to 1.03, marking an increase of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.04. This value is within the healthy range. It has increased from 3.22 (Mar 24) to 4.04, marking an increase of 0.82.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.36. This value is below the healthy minimum of 20. It has increased from -62.41 (Mar 24) to 8.36, marking an increase of 70.77.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.05. This value is below the healthy minimum of 20. It has decreased from 47.92 (Mar 24) to 2.05, marking a decrease of 45.87.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.64. This value exceeds the healthy maximum of 70. It has decreased from 162.41 (Mar 24) to 91.64, marking a decrease of 70.77.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.95. This value exceeds the healthy maximum of 70. It has increased from 52.08 (Mar 24) to 97.95, marking an increase of 45.87.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.23. This value is below the healthy minimum of 3. It has increased from 1.30 (Mar 24) to 2.23, marking an increase of 0.93.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 3. It has increased from 0.64 (Mar 24) to 1.47, marking an increase of 0.83.
- For Enterprise Value (Cr.), as of Mar 25, the value is 70,381.90. It has increased from 61,503.75 (Mar 24) to 70,381.90, marking an increase of 8,878.15.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 1.43 (Mar 24) to 1.51, marking an increase of 0.08.
- For EV / EBITDA (X), as of Mar 25, the value is 8.70. This value is within the healthy range. It has decreased from 12.25 (Mar 24) to 8.70, marking a decrease of 3.55.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.08, marking an increase of 0.29.
- For Retention Ratios (%), as of Mar 25, the value is 91.63. This value exceeds the healthy maximum of 70. It has decreased from 162.41 (Mar 24) to 91.63, marking a decrease of 70.78.
- For Price / BV (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 1.73, marking an increase of 0.35.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.08, marking an increase of 0.29.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.03 (Mar 24) to 0.01, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in UPL Ltd:
- Net Profit Margin: 2.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.97% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.07% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.47
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.03
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.5 (Industry average Stock P/E: 28.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.81
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.77%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | 3-11, G.I.D.C., Vapi, Valsad District Gujarat 396195 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajnikant D Shroff | Chairman Emeritus |
| Mr. Jaidev R Shroff | Chairman & Group CEO |
| Mr. Vikram R Shroff | Vice Chairman |
| Mr. Raj Tiwari | Whole Time Director |
| Mr. Hardeep Singh | Non Executive Director |
| Mr. S K Mohanty | Independent Director |
| Dr. Vasant Gandhi | Independent Director |
| Ms. Naina Lal Kidwai | Independent Director |
| Mr. Suresh Kumar | Lead Independent Director |
| Ms. Usha Monari | Independent Director |
| Ms. M V Bhanumathi | Independent Director |
FAQ
What is the intrinsic value of UPL Ltd?
UPL Ltd's intrinsic value (as of 29 January 2026) is ₹232.13 which is 67.58% lower the current market price of ₹716.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹60,410 Cr. market cap, FY2025-2026 high/low of ₹812/555, reserves of ₹31,725 Cr, and liabilities of ₹91,391 Cr.
What is the Market Cap of UPL Ltd?
The Market Cap of UPL Ltd is 60,410 Cr..
What is the current Stock Price of UPL Ltd as on 29 January 2026?
The current stock price of UPL Ltd as on 29 January 2026 is ₹716.
What is the High / Low of UPL Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of UPL Ltd stocks is ₹812/555.
What is the Stock P/E of UPL Ltd?
The Stock P/E of UPL Ltd is 25.5.
What is the Book Value of UPL Ltd?
The Book Value of UPL Ltd is 378.
What is the Dividend Yield of UPL Ltd?
The Dividend Yield of UPL Ltd is 0.84 %.
What is the ROCE of UPL Ltd?
The ROCE of UPL Ltd is 7.66 %.
What is the ROE of UPL Ltd?
The ROE of UPL Ltd is 3.29 %.
What is the Face Value of UPL Ltd?
The Face Value of UPL Ltd is 2.00.